A medical technology company.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Sanara MedTech Inc. in the last 30 days yet.
The 1 sources with the most insights about Sanara MedTech Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Considered a 'hold' but not a buy. Its valuation metric is 'pretty good', but its 25% revenue growth is not compelling enough compared to faster-growing peers.
Considered a 'hold' but not a buy. Its valuation metric is 'pretty good', but its 25% revenue growth is not compelling enough compared to faster-growing peers.
Other assets that creators frequently mention in the same content as Sanara MedTech Inc..
The most active sources covering Sanara MedTech Inc. (SMTI) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Sanara MedTech Inc. (SMTI) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Sanara MedTech Inc. (SMTI) most frequently also discuss MARA, MTPLF, SBET, STRK, HOOD. See the "Discussed alongside" section above for full asset pages.